{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T23:59:00Z","timestamp":1791935940796,"version":"4.3.4"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ijcard.2026.134504","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T23:10:00Z","timestamp":1776294600000},"page":"134504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Association between Ranolazine use and outcomes in patients with suspected MINOCA: A propensity-matched cohort study"],"prefix":"10.1016","volume":"455","author":[{"given":"Jheng-Yan","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keng-Wei","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Chi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsuan-Yuan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Min","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.ijcard.2026.134504_bb0005","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.114.011201","article-title":"Systematic review of patients presenting with suspected myocardial infarction and nonobstructive coronary arteries","volume":"131","author":"Pasupathy","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2026.134504_bb0010","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ahj.2009.08.004","volume":"158","author":"Gehrie","year":"2009","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2026.134504_bb0015","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/joim.12857","article-title":"Morbidity and cause-specific mortality in first-time myocardial infarction with nonobstructive coronary arteries","volume":"285","author":"Eggers","year":"2019","journal-title":"J. Intern. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2026.134504_bb0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11897-023-00605-1","article-title":"MINOCA and INOCA: role in heart failure","volume":"20","author":"Almeida","year":"2023","journal-title":"Curr. Heart Fail. Rep."},{"issue":"11","key":"10.1016\/j.ijcard.2026.134504_bb0025","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.121.007880","article-title":"Survival in patients with suspected myocardial infarction with nonobstructive coronary arteries: a comprehensive systematic review and meta-analysis from the MINOCA global collaboration","volume":"14","author":"Pasupathy","year":"2021","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"key":"10.1016\/j.ijcard.2026.134504_bb0030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2022.08.034","article-title":"Impact of secondary prevention medical therapies on outcomes of patients suffering from myocardial infarction with NonObstructive coronary artery disease (MINOCA): a meta-analysis","volume":"368","author":"De Filippo","year":"2022","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2026.134504_bb0035","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jama.291.3.309","article-title":"Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial","volume":"291","author":"Chaitman","year":"2004","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.ijcard.2026.134504_bb0040","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1001\/jama.297.16.1775","article-title":"Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial","volume":"297","author":"Morrow","year":"2007","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.ijcard.2026.134504_bb0045","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jfma.2024.09.018","article-title":"Ranolazine effects on exercise tolerance and angina frequency in Taiwanese stable angina: a bridging study of the CARISA randomized trial","volume":"124","author":"Lee","year":"2025","journal-title":"J. Formos. Med. Assoc."},{"issue":"2","key":"10.1016\/j.ijcard.2026.134504_bb0050","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.21037\/qims-23-1029","article-title":"Ranolazine for improving coronary microvascular function in patients with nonobstructive coronary artery disease: a systematic review and meta-analysis with a trial sequential analysis of randomized controlled trials","volume":"14","author":"Ling","year":"2024","journal-title":"Quant. Imaging Med. Surg."},{"issue":"12","key":"10.1016\/j.ijcard.2026.134504_bb0055","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1007\/s00392-023-02294-1","article-title":"Coronary microvascular dysfunction is a hallmark of all subtypes of MINOCA","volume":"113","author":"Milzi","year":"2024","journal-title":"Clin. Res. Cardiol."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2026.134504_bb0060","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.4103\/sja.SJA_543_18","article-title":"The STROBE guidelines","volume":"13","author":"Cuschieri","year":"2019","journal-title":"Saudi J Anaesth"},{"issue":"15","key":"10.1016\/j.ijcard.2026.134504_bb0065","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/jama.2015.13480","article-title":"The propensity score","volume":"314","author":"Haukoos","year":"2015","journal-title":"Jama"},{"issue":"16","key":"10.1016\/j.ijcard.2026.134504_bb0070","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/CIRCULATIONAHA.116.026336","article-title":"Medical therapy for secondary prevention and long-term outcome in patients with myocardial infarction with nonobstructive coronary artery disease","volume":"135","author":"Lindahl","year":"2017","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2026.134504_bb0075","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2026.134504_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133039","article-title":"Temporal trends of characteristics and management of patients with suspected MINOCA","volume":"424","author":"Ciliberti","year":"2025","journal-title":"Int. J. Cardiol."},{"issue":"7","key":"10.1016\/j.ijcard.2026.134504_bb0085","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/eurheartj\/ehz403","article-title":"Myocardial infarction with non-obstructive coronary arteries as compared with myocardial infarction and obstructive coronary disease: outcomes in a medicare population","volume":"41","author":"Dreyer","year":"2020","journal-title":"Eur. Heart J."},{"issue":"7","key":"10.1016\/j.ijcard.2026.134504_bb0090","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/heartjnl-2018-313665","article-title":"Outcome after myocardial infarction without obstructive coronary artery disease","volume":"105","author":"Williams","year":"2019","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2026.134504_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ijcard.2020.11.040","article-title":"Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): insights from a multicentre national registry","volume":"327","author":"Ciliberti","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134504_bb0100","article-title":"Colchicine and cardiovascular outcomes in MINOCA: a retrospective cohort study","volume":"60","author":"Oro","year":"2025","journal-title":"Am Heart J Plus."},{"issue":"1","key":"10.1016\/j.ijcard.2026.134504_bb0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.amjmed.2019.05.048","article-title":"Predictors of mortality in myocardial infarction and nonobstructed coronary arteries: a systematic review and Meta-regression","volume":"133","author":"Pelliccia","year":"2020","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ijcard.2026.134504_bb0110","article-title":"Secondary prevention medical therapy and outcomes in patients with myocardial infarction with non-obstructive coronary artery disease","volume":"10","author":"Paolisso","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"13","key":"10.1016\/j.ijcard.2026.134504_bb0115","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/j.jacc.2021.07.042","article-title":"Coronary microvascular dysfunction across the spectrum of cardiovascular diseases: JACC state-of-the-art review","volume":"78","author":"Del Buono","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2026.134504_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/jcm14041128","article-title":"Coronary microvascular dysfunction and vasospastic angina-pathophysiology, diagnosis and management strategies","volume":"14","author":"Abramik","year":"2025","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2026.134504_bb0125","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1007\/s12350-022-03000-w","article-title":"Phenotype-based management of coronary microvascular dysfunction","volume":"29","author":"Ang","year":"2022","journal-title":"J. Nucl. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2026.134504_bb0130","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4244\/EIJ-D-24-00404","article-title":"A systematic review of enrolment criteria and treatment efficacy for microvascular angina","volume":"21","author":"Hammond-Haley","year":"2025","journal-title":"EuroIntervention"},{"issue":"5","key":"10.1016\/j.ijcard.2026.134504_bb0135","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s40256-020-00462-6","article-title":"Use of ranolazine for the treatment of coronary microvascular dysfunction","volume":"21","author":"Sharp","year":"2021","journal-title":"Am. J. Cardiovasc. Drugs"},{"issue":"19","key":"10.1016\/j.ijcard.2026.134504_bb0140","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/eurheartj\/ehv647","article-title":"A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve","volume":"37","author":"Bairey Merz","year":"2016","journal-title":"Eur. Heart J."},{"issue":"6","key":"10.1016\/j.ijcard.2026.134504_bb0145","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.carrev.2017.04.012","article-title":"Impact of ranolazine on coronary microvascular dysfunction (MICRO) study","volume":"18","author":"Ahmed","year":"2017","journal-title":"Cardiovasc. Revasc. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2026.134504_bb0150","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/CIRCRESAHA.111.258251","article-title":"Ranolazine improves cardiac diastolic dysfunction through modulation of myofilament calcium sensitivity","volume":"110","author":"Lovelock","year":"2012","journal-title":"Circ. Res."},{"issue":"Suppl 4(Suppl 4)","key":"10.1016\/j.ijcard.2026.134504_bb0155","doi-asserted-by":"crossref","first-page":"iv6","DOI":"10.1136\/hrt.2005.078790","article-title":"Inhibition of the late sodium current as a potential cardioprotective principle: effects of the late sodium current inhibitor ranolazine","volume":"92","author":"Belardinelli","year":"2006","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.ijcard.2026.134504_bb0160","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s00392-007-0612-y","article-title":"Mechanism of action of the new anti-ischemia drug ranolazine","volume":"97","author":"Hasenfuss","year":"2008","journal-title":"Clin. Res. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2026.134504_bb0165","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s12350-011-9364-1","article-title":"The effect of ranolazine on the vasodilator-induced myocardial perfusion abnormality","volume":"18","author":"Venkataraman","year":"2011","journal-title":"J. Nucl. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2026.134504_bb0170","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/echo.12674","article-title":"Effects of ranolazine on noninvasive coronary flow reserve in patients with myocardial ischemia but without obstructive coronary artery disease","volume":"32","author":"Tagliamonte","year":"2015","journal-title":"Echocardiography"},{"issue":"1","key":"10.1016\/j.ijcard.2026.134504_bb0175","doi-asserted-by":"crossref","first-page":"H189","DOI":"10.1152\/ajpheart.00217.2019","article-title":"Ranolazine may exert its beneficial effects by increasing myocardial adenosine levels","volume":"318","author":"Le","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"Supplement_2","key":"10.1016\/j.ijcard.2026.134504_bb0180","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad655.1559","article-title":"Incidence and predictors of heart failure in a cohort of MINOCA patients","volume":"44","author":"Ryabenko","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2026.134504_bb0185","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijcard.2023.01.019","article-title":"Updates on MINOCA and INOCA through the 2022 publications in the international journal of cardiology","volume":"374","author":"Pelliccia","year":"2023","journal-title":"Int. J. Cardiol."},{"issue":"16","key":"10.1016\/j.ijcard.2026.134504_bb0190","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1161\/CIRCULATIONAHA.117.027666","article-title":"Myocardial infarction with nonobstructive coronary arteries (MINOCA): the past, present, and future management","volume":"135","author":"Pasupathy","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2026.134504_bb0195","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/eurheartj\/ehw149","article-title":"ESC working group position paper on myocardial infarction with non-obstructive coronary arteries","volume":"38","author":"Agewall","year":"2017","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.ijcard.2026.134504_bb0200","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1093\/eurheartj\/ehaf917","article-title":"Stratified treatment of myocardial infarction with non-obstructive coronary arteries: the PROMISE trial","volume":"47","author":"Montone","year":"2026","journal-title":"Eur. Heart J."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326003530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326003530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:52:01Z","timestamp":1789091521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527326003530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":40,"alternative-id":["S0167527326003530"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134504","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between Ranolazine use and outcomes in patients with suspected MINOCA: A propensity-matched cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"134504"}}